Alvotech Files Routine 6-K with SEC
Ticker: ALVOW · Form: 6-K · Filed: Jul 22, 2024 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Jul 22, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, routine-filing, foreign-private-issuer
TL;DR
Alvotech filed a 6-K, confirming 20-F annual report filing. No new info, just procedure.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on July 22, 2024, indicating it will file its annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates but serves as a routine submission for foreign private issuers.
Why It Matters
This filing is a standard procedural document for foreign private issuers like Alvotech, confirming their reporting obligations and format with the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing with no new material financial or operational information that would typically impact stock price.
Key Players & Entities
- Alvotech (company) — Filer of the 6-K
- 001-41421 (company) — SEC File Number
- 20240722 (date) — Filing Date
FAQ
What type of filing is this Form 6-K?
This is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
Which annual report form will Alvotech file?
Alvotech indicates it files annual reports under cover of Form 20-F.
What is the Commission File Number for Alvotech?
The Commission File Number for Alvotech is 001-41421.
What is the principal executive office address of Alvotech?
The principal executive office address is 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
Does this filing contain specific financial results or operational updates?
No, this Form 6-K appears to be a routine administrative filing and does not contain specific financial results or operational updates within the provided text.
Filing Stats: 336 words · 1 min read · ~1 pages · Grade level 12.7 · Accepted 2024-07-22 07:06:28
Filing Documents
- f6k_072224.htm (6-K) — 7KB
- exh_991.htm (EX-99.1) — 15KB
- 0001171843-24-004052.txt ( ) — 23KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: July 22, 2024 /s/ Tanya Zharov Tanya Zharov General Counsel